Suppr超能文献

白藜芦醇与眼科疾病

Resveratrol and Ophthalmic Diseases.

作者信息

Abu-Amero Khaled K, Kondkar Altaf A, Chalam Kakarla V

机构信息

Department of Ophthalmology, University of Florida College of Medicine, FL 32209, USA.

Glaucoma Research Chair, Department of Ophthalmology, College of Medicine, King Saud University, Riyadh 11424, Saudi Arabia.

出版信息

Nutrients. 2016 Apr 5;8(4):200. doi: 10.3390/nu8040200.

Abstract

Resveratrol, a naturally occurring plant polyphenol found in grapes, is the principal biologically active component in red wine. Clinical studies have shown that resveratrol due to its potent anti-oxidant and anti-inflammatory properties are cardio-protective, chemotherapeutic, neuroprotective, and display anti-aging effects. Oxidative stress and inflammation play a critical role in the initiation and progression of age-related ocular diseases (glaucoma, cataract, diabetic retinopathy and macular degeneration) that lead to progressive loss of vision and blindness. In vitro and in vivo (animal model) experimental studies performed so far have provided evidence for the biological effects of resveratrol on numerous pathways including oxidative stress, inflammation, mitochondrial dysfunction, apoptosis, pro-survival or angiogenesis that are implicated in the pathogenesis of these age-related ocular disorders. In this review, we provide a brief overview of current scientific literature on resveratrol, its plausible mechanism(s) of action, its potential use and current limitations as a nutritional therapeutic intervention in the eye and its related disorders.

摘要

白藜芦醇是一种存在于葡萄中的天然植物多酚,是红酒中的主要生物活性成分。临床研究表明,白藜芦醇因其强大的抗氧化和抗炎特性,具有心脏保护、化疗、神经保护作用,并显示出抗衰老效果。氧化应激和炎症在导致视力逐渐丧失和失明的与年龄相关的眼部疾病(青光眼、白内障、糖尿病视网膜病变和黄斑变性)的发生和发展中起关键作用。迄今为止进行的体外和体内(动物模型)实验研究为白藜芦醇对包括氧化应激、炎症、线粒体功能障碍、细胞凋亡、促生存或血管生成等众多途径的生物学效应提供了证据,这些途径与这些与年龄相关的眼部疾病的发病机制有关。在这篇综述中,我们简要概述了关于白藜芦醇的当前科学文献,其可能的作用机制,其作为眼部及其相关疾病的营养治疗干预措施的潜在用途和当前局限性。

相似文献

1
Resveratrol and Ophthalmic Diseases.
Nutrients. 2016 Apr 5;8(4):200. doi: 10.3390/nu8040200.
2
Resveratrol and the eye: activity and molecular mechanisms.
Graefes Arch Clin Exp Ophthalmol. 2014 May;252(5):699-713. doi: 10.1007/s00417-014-2604-8. Epub 2014 Mar 21.
3
A focus on resveratrol and ocular problems, especially cataract: From chemistry to medical uses and clinical relevance.
Biomed Pharmacother. 2017 Feb;86:232-241. doi: 10.1016/j.biopha.2016.11.141. Epub 2016 Dec 19.
4
The Role of Resveratrol in Eye Diseases-A Review of the Literature.
Nutrients. 2022 Jul 20;14(14):2974. doi: 10.3390/nu14142974.
5
6
Phytochemicals and age-related eye diseases.
Nutr Rev. 2008 Aug;66(8):465-72. doi: 10.1111/j.1753-4887.2008.00078.x.
7
Resveratrol and related stilbenes: their anti-aging and anti-angiogenic properties.
Food Chem Toxicol. 2013 Nov;61:112-20. doi: 10.1016/j.fct.2013.03.038. Epub 2013 Apr 6.
8
Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications.
Biochem Soc Trans. 2007 Nov;35(Pt 5):1156-60. doi: 10.1042/BST0351156.
10
Health Benefits of Polyphenols and Carotenoids in Age-Related Eye Diseases.
Oxid Med Cell Longev. 2019 Feb 12;2019:9783429. doi: 10.1155/2019/9783429. eCollection 2019.

引用本文的文献

1
Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds.
Biomed Pharmacother. 2025 Sep;190:118319. doi: 10.1016/j.biopha.2025.118319. Epub 2025 Jul 18.
2
Targeting oxidative stress in diabetic retinopathy: mechanisms, pathology, and novel treatment approaches.
Front Immunol. 2025 Jun 16;16:1571576. doi: 10.3389/fimmu.2025.1571576. eCollection 2025.
3
Exploring the Gut Microbiota-Retina Axis: Implications for Health and Disease.
Microorganisms. 2025 May 10;13(5):1101. doi: 10.3390/microorganisms13051101.
4
Protective effects of carotenoids against blue light induced-cellular damage in human retinal pigment epithelium.
Food Sci Biotechnol. 2025 Jan 27;34(8):1713-1723. doi: 10.1007/s10068-024-01757-z. eCollection 2025 Apr.
8
Evaluating the impact of caloric restriction, body mass index and exercise on primary open-angle glaucoma: A review.
Eur J Ophthalmol. 2025 Mar;35(2):429-440. doi: 10.1177/11206721241274445. Epub 2024 Aug 22.
9
Clinical management of eye diseases: carotenoids and their nanoformulations as choice of therapeutics.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):329-349. doi: 10.1007/s00210-024-03376-1. Epub 2024 Aug 21.
10
Consilience and unity in ocular anterior segment research.
Int J Ophthalmol. 2024 Jul 18;17(7):1173-1183. doi: 10.18240/ijo.2024.07.01. eCollection 2024.

本文引用的文献

1
Retinal ganglion cell apoptotic pathway in glaucoma: Initiating and downstream mechanisms.
Prog Brain Res. 2015;220:37-57. doi: 10.1016/bs.pbr.2015.05.005. Epub 2015 Oct 1.
2
Mitochondrial DNA has a pro-inflammatory role in AMD.
Biochim Biophys Acta. 2015 Nov;1853(11 Pt A):2897-906. doi: 10.1016/j.bbamcr.2015.08.012. Epub 2015 Aug 21.
3
Oxidative stress, mitochondrial damage and diabetic retinopathy.
Biochim Biophys Acta. 2015 Nov;1852(11):2474-83. doi: 10.1016/j.bbadis.2015.08.001. Epub 2015 Aug 4.
4
Protection of injured retinal ganglion cell dendrites and unfolded protein response resolution after long-term dietary resveratrol.
Neurobiol Aging. 2015 May;36(5):1969-81. doi: 10.1016/j.neurobiolaging.2014.12.021. Epub 2015 Jan 28.
5
Riluzole- and Resveratrol-Induced Delay of Retinal Ganglion Cell Death in an Experimental Model of Glaucoma.
Curr Eye Res. 2016;41(1):59-69. doi: 10.3109/02713683.2015.1004719. Epub 2015 Feb 6.
6
Resveratrol nanoformulations: challenges and opportunities.
Int J Pharm. 2015 Feb 20;479(2):282-90. doi: 10.1016/j.ijpharm.2015.01.003. Epub 2015 Jan 5.
7
9
Role of adenosine receptors in resveratrol-induced intraocular pressure lowering in rats with steroid-induced ocular hypertension.
Clin Exp Ophthalmol. 2015 Jan-Feb;43(1):54-66. doi: 10.1111/ceo.12375. Epub 2014 Nov 20.
10
The pathophysiology and treatment of glaucoma: a review.
JAMA. 2014 May 14;311(18):1901-11. doi: 10.1001/jama.2014.3192.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验